Gudmar Thorleifsson

Gudmar Thorleifsson

Auto-generated profile, based on publicly available information

Gudmar Thorleifsson

DeCODE genetics/AMGEN Inc., Reykjavik, Iceland

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 January 2018 in Science
Verified
Journal Article
Closed access
PDF file
AKAugustine Kong
Augustine Kong
GTGudmar Thorleifsson
Gudmar Thorleifsson
MFMichael L. Frigge
Michael L. Frigge
BVBjarni J. Vilhjalmsson
Bjarni J. Vilhjalmsson
AYAlexander I. Young
Alexander I. Young
KSKari Stefansson
Kari Stefansson
Genetic variants provide a nurturing environment: Genetic variants in parents may affect the fitness of their offspring, even if the child does not carry the allele. This indirect effect is referred to as “genetic nurture.” Kong et al. used data from genome-wide association studies of educational attainment to construct polygenic scores for parents that only considered the nontransmitted alleles (see the Perspective by Koellinger and Harden). The findings suggest that genetic nurture is ultimately due to genetic variation in the population and is mediated by the environment that parents create for their children. Science , this issue p. 424 ; see also p. 386

6 December 2022 in Nature Genetics
Verified
Journal Article
Open access
PDF file
KAKrishna G. Aragam
Krishna G. Aragam
TJTao Jiang
Tao Jiang
AGAnuj Goel
Anuj Goel
Stavroula KanoniStavroula Kanoni
Stavroula Kanoni
BWBrooke N. Wolford
Brooke N. Wolford
ECEpic- Cvd
Epic- Cvd
The discovery of genetic loci associated with complex diseases has outpaced the elucidation of mechanisms of disease pathogenesis. Here we conducted a genome-wide association study (GWAS) for coronary artery disease (CAD) comprising 181,522 cases among 1,165,690 participants of predominantly European ancestry. We detected 241 associations, including 30 new loci. Cross-ancestry meta-analysis with a Japanese GWAS yielded 38 additional new loci. We prioritized likely causal variants using functionally informed fine-mapping, yielding 42 associations with less than five variants in the 95% credible set. Similarity-based clustering suggested roles for early developmental processes, cell cycle signaling and vascular cell migration and proliferation in the pathogenesis of CAD. We prioritized 220 candidate causal genes, combining eight complementary approaches, including 123 supported by three or more approaches. Using CRISPR–Cas9, we experimentally validated the effect of an enhancer in MYO9B, which appears to mediate CAD risk by regulating vascular cell motility. Our analysis identifies and systematically characterizes >250 risk loci for CAD to inform experimental interrogation of putative causal mechanisms for CAD.

4 October 2023 in Nature
Verified
Journal Article
Open access
PDF file
GEGrímur Hjörleifsson Eldjárn
Grímur Hjörleifsson Eldjárn
EFEgil Ferkingstad
Egil Ferkingstad
SLSigrun H. Lund
Sigrun H. Lund
HHHannes Helgason
Hannes Helgason
OMOlafur Th. Magnusson
Olafur Th. Magnusson
KSKari Stefansson
Kari Stefansson
High-throughput proteomics platforms measuring thousands of proteins in plasma combined with genomic and phenotypic information have the power to bridge the gap between the genome and diseases. Here we performed association studies of Olink Explore 3072 data generated by the UK Biobank Pharma Proteomics Project1 on plasma samples from more than 50,000 UK Biobank participants with phenotypic and genotypic data, stratifying on British or Irish, African and South Asian ancestries. We compared the results with those of a SomaScan v4 study on plasma from 36,000 Icelandic people2, for 1,514 of whom Olink data were also available. We found modest correlation between the two platforms. Although cis protein quantitative trait loci were detected for a similar absolute number of assays on the two platforms (2,101 on Olink versus 2,120 on SomaScan), the proportion of assays with such supporting evidence for assay performance was higher on the Olink platform (72% versus 43%). A considerable number of proteins had genomic associations that differed between the platforms. We provide examples where differences between platforms may influence conclusions drawn from the integration of protein levels with the study of diseases. We demonstrate how leveraging the diverse ancestries of participants in the UK Biobank helps to detect novel associations and refine genomic location. Our results show the value of the information provided by the two most commonly used high-throughput proteomics platforms and demonstrate the differences between them that at times provides useful complementarity.

25 January 2019 in Science
Verified
Journal Article
Closed access
PDF file
BHBjarni V. Halldorsson
Bjarni V. Halldorsson
GPGunnar Palsson
Gunnar Palsson
OSOlafur A. Stefansson
Olafur A. Stefansson
HJHakon Jonsson
Hakon Jonsson
MHMarteinn T. Hardarson
Marteinn T. Hardarson
KSKari Stefansson
Kari Stefansson
Human recombination and mutation mapped: Genetic recombination is an essential process in generating genetic diversity. Recombination occurs both through the shuffling of maternal and paternal chromosomes and through mutations generated by resolution of the physical breaks necessary for this process. Halldorsson et al. sequenced the full genomes of parents and offspring to create a map of human recombination and estimate the relationship with de novo mutations. Interestingly, transcribed regions of the genome were less likely to have crossovers, suggesting that there may be selection to reduce changes in genetic sequences via recombination or mutation in these regions. Science , this issue p. eaau1043

13 March 2023 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
NRNilufer Rahmioglu
Nilufer Rahmioglu
SMSally Mortlock
Sally Mortlock
MGMarzieh Ghiasi
Marzieh Ghiasi
PMPeter L Møller
Peter L Møller
LSLilja Stefansdottir
Lilja Stefansdottir
KZKrina Zondervan
Krina Zondervan

24 October 2022 in Nature Genetics
Verified
Journal Article
Open access
PDF file
GSGardar Sveinbjornsson
Gardar Sveinbjornsson
MUMagnus O. Ulfarsson
Magnus O. Ulfarsson
RTRosa B. Thorolfsdottir
Rosa B. Thorolfsdottir
BJBenedikt A. Jonsson
Benedikt A. Jonsson
EEEythor Einarsson
Eythor Einarsson
KSKari Stefansson
Kari Stefansson
Nonalcoholic fatty liver (NAFL) and its sequelae are growing health problems. We performed a genome-wide association study of NAFL, cirrhosis and hepatocellular carcinoma, and integrated the findings with expression and proteomic data. For NAFL, we utilized 9,491 clinical cases and proton density fat fraction extracted from 36,116 liver magnetic resonance images. We identified 18 sequence variants associated with NAFL and 4 with cirrhosis, and found rare, protective, predicted loss-of-function variants inMTARC1andGPAM, underscoring them as potential drug targets. We leveraged messenger RNA expression, splicing and predicted coding effects to identify 16 putative causal genes, of which many are implicated in lipid metabolism. We analyzed levels of 4,907 plasma proteins in 35,559 Icelanders and 1,459 proteins in 47,151 UK Biobank participants, identifying multiple proteins involved in disease pathogenesis. We show that proteomics can discriminate between NAFL and cirrhosis. The present study provides insights into the development of noninvasive evaluation of NAFL and new therapeutic options.